Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Bio-Thera SolutionsSHSE:688177 -3.38%57 Days Payable is 431.41 as of Mar. 2026, which is 36% below its 10-year median of 668.88. GuruFocus rates SHSE:688177 with a GF Score™ of 57/100 and a GF Value™ of ¥33.46 (Possible Value Trap). The stock has 5 warning signs investors should review. Among 702 Biotechnology companies, Bio-Thera Solutions ranks better than 74.64% on this metric.
The historical rank and industry rank for Bio-Thera Solutions's Days Payable or its related term are showing as below:
SHSE:688177'
s Days Payable Range Over the Past 10 Years
Min: 123.94 Med: 668.88 Max: 360159.47
Current: 374.38
During the past 10 years, Bio-Thera Solutions's highest Days Payable was 360159.47. The lowest was 123.94. And the median was 668.88.
SHSE:688177's Days Payable is ranked better than 74.64% of 702
companies
in the Biotechnology industry
Industry Median: 113.1
vs SHSE:688177: 374.38
Bio-Thera Solutions's Days Payable
increased
from Mar. 2025 (377.27) to Mar. 2026 (431.41).
It may suggest that Bio-Thera Solutionsdelayed paying its suppliers.
Bio-Thera Solutions Days Payable Related Terms
Bio-Thera Solutions Days Payable Historical Data
* Premium members only.
The historical data trend for Bio-Thera Solutions's Days Payable can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
SHSE:688177 vs VRTX, REGN, ALNY: Days Payable Comparison
For the Biotechnology subindustry, Bio-Thera Solutions's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Bio-Thera Solutions Days Payable vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Bio-Thera Solutions's Days Payable distribution charts can be found below:
* The bar in red indicates where Bio-Thera Solutions's Days Payable falls into.
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
Bio-Thera Solutions's Days Payable for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Bio-Thera Solutions (SHSE:688177) has a Days Payable of 431.41 as of Mar. 2026. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Bio-Thera Solutions and its competitors. This is 36% below median its historical median of 668.88. Over the past decade, Bio-Thera Solutions' Days Payable has ranged from 123.94 to 360,159.47. According to the industry distribution chart, Bio-Thera Solutions ranks #178 out of 702 companies in the Biotechnology industry, placing it in the top 25.4%.
Is Bio-Thera Solutions' Days Payable too high?
Bio-Thera Solutions' current Days Payable of 431.41 is 36% below median its 10-year median of 668.88. Over the past 10 years, this metric has ranged from a low of 123.94 to a high of 360,159.47. The Biotechnology industry median Days Payable is 113.10. Bio-Thera Solutions' value of 431.41 is 281.4% above this industry median. Based on the distribution chart, Bio-Thera Solutions ranks #178 out of 702 companies in the Biotechnology industry, which is above the industry midpoint. Overall, Bio-Thera Solutions has a GF Score™ of 57/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Bio-Thera Solutions' Days Payable compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Bio-Thera Solutions ranks #178 out of 702 companies for Days Payable. This puts Bio-Thera Solutions in the upper half of its industry. The industry median Days Payable is 113.10. Bio-Thera Solutions' value of 431.41 is 281.4% above this benchmark. Historically, Bio-Thera Solutions' own Days Payable has ranged from 123.94 to 360,159.47 over the past decade. While the company's 10-year median is 668.88 vs. the industry median of 113.10, Bio-Thera Solutions has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Biotechnology company?
The median Days Payable among Biotechnology companies is 113.10, based on 702 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Bio-Thera Solutions's current Days Payable of 431.41 is 281.4% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Bio-Thera Solutions and its competitors. For the Biotechnology industry, the median Days Payable is 113.10 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Bio-Thera Solutions's current Days Payable is 431.41, which is 36% below median its own 10-year median of 668.88. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Bio-Thera Solutions stock overvalued right now?
Based on GuruFocus' analysis, Bio-Thera Solutions (SHSE:688177) is currently considered Possible Value Trap. The stock's GF Value™ is ¥33.46, compared to a current price of ¥16.58 — trading 50.4% below its estimated fair value. The current Days Payable is 431.41, which is 36% below median its 10-year median of 668.88 and 281.4% above the Biotechnology industry median of 113.10. Bio-Thera Solutions' overall GF Score™ is 57/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For Bio-Thera Solutions (SHSE:688177), the current Days Payable is 431.41 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Bio-Thera Solutions (SHSE:688177) Overvalued in 2026?
Based on GuruFocus' analysis, Bio-Thera Solutions stock appears to be undervalued.
The current stock price of ¥16.58 is trading 50.4% below its estimated GF Value™ of ¥33.46.
GuruFocus considers Bio-Thera Solutions to be Possible Value Trap.
Key valuation signals for SHSE:688177:
Days Payable: 431.41 (36% below median its 10-year median of 668.88)
GF Value™: ¥33.46 vs. price of ¥16.58 (50.4% below fair value)
Industry Position: 281.4% above the Biotechnology median (#178 of 702)
No single metric tells the full story. See the SHSE:688177 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Bio-Thera Solutions Ltd is engaged in research, development, and production of drugs and biosimilars. The company provides drug research and development; biotechnology consulting and communication services; services; medical research and experimental development; biological drug manufacturing; and pharmaceuticals retail.
57GF Score
Get the complete analysis for SHSE:688177
Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SHSE:688177 has been successfully added to your 
